IP Library Granted Patent US 9,827,565
Granted Patent B2
US 9,827,565 · App. 15/293,062 · Granted Nov 28, 2017

Nucleic acid sample preparation

Inventors: Rajaram Krishnan (San Diego, CA); David Charlot (San Diego, CA); Eugene Tu (San Diego, CA); James McCanna (San Diego, CA); Lucas Kumosa (Centennial, CO); Paul Swanson (Santee, CA); Robert Turner (San Diego, CA); Kai Yang (San Diego, CA); Irina Dobrovolskaya (San Diego, CA); David Liu (San Diego, CA)
Assignee: BIOLOGICAL DYNAMICS, INC.
B01L3/502715B01D57/02B01L7/52B03C5/005B03C5/026B03C7/023C12N15/101C12N15/1003C12Q1/6806G01N27/447G01N27/44704G01S5/163G06F3/0346B01L2300/0636B01L2300/0645B01L2400/0424B03C2201/26G01S11/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,827,565
App. No.
15/293,062
Granted
Nov 28, 2017
Kind
B2
Abstract

The present invention includes methods, devices and systems for isolating a nucleic acid from a fluid comprising cells. In various aspects, the methods, devices and systems may allow for a rapid procedure that requires a minimal amount of material and/or results in high purity nucleic acid isolated from complex fluids such as blood or environmental samples.

Claims (24)

1. A device for isolating DNA from a fluid comprising cells, the device comprising:

a. a first array of electrodes capable of establishing a first AC electrokinetic field region, wherein the first AC electrokinetic field region is a first dielectrophoretic low field region capable of concentrating and lysing a plurality of cells in a conductivity of fluid of 100 mS/m or more;

b. a second array of electrodes capable of establishing a second AC electrokinetic field, wherein the second AC eletrokinetic field is a dieletrophoretic high field region capable of concentrating and isolating nucleic acid in a conductivity of fluid of 100 mS/m or more;

c. a reservoir comprising a fluid and a device for flushing residual and lysed cellular material from the first array of electrodes; and

d. a module capable of performing sequencing.

2. The device of claim 1 , wherein the first and second array of electrodes are configured to be selectively energized to establish a dielectrophoretic high field and dielectrophoretic low field regions.

3. The device of claim 1 , wherein the first array of electrodes and the second array of electrodes is in a wavy or nonlinear line configuration, wherein the configuration comprises a repeating unit comprising the shape of a pair of dots connected by a linker, wherein the dots and linker define the boundaries of the electrode, wherein the linker tapers inward towards or at the midpoint between the pair of dots, wherein the diameters of the dots are the widest points along the length of the repeating unit, wherein the edge to edge distance between a parallel set of repeating units is equidistant, or roughly equidistant.

4. The device of claim 1 , wherein nucleic acid is isolated and sequencing is performed in a single chamber.

5. The device of claim 1 , wherein nucleic acid is isolated and sequencing is performed in multiple regions of a single chamber.

6. The device of claim 1 , further comprising using at least one of an elution tube, a chamber and a reservoir to perform sequencing.

7. The device of claim 1 , wherein sequencing of the nucleic acid is performed in a serpentine microchannel comprising a plurality of temperature zones.

8. The device of claim 1 , wherein sequencing is performed in aqueous droplets entrapped in immiscible fluids.

9. The device of claim 1 , wherein the device comprises a module capable of thermocycling and amplifying nucleic acids.

10. The device of claim 1 , wherein the device comprises a surface contacting or proximal to the electrodes, wherein the surface is functionalized with biological ligands that are capable of selectively capturing biomolecules.

11. The device of any of claim 1 , wherein the array of electrodes is coated with a hydrogel.

12. The device of claim 11 , wherein the hydrogel comprises two or more layers of a synthetic polymer.

13. The device of claim 11 , wherein the hydrogel is spin-coated onto the electrodes.

14. The device of claim 11 , wherein the hydrogel has a viscosity between about 0.5 cP to about 5 cP prior to spin-coating.

15. The device of any claim 11 , wherein the hydrogel has a thickness between about 0.01 microns and 1 micron.

16. The device of any of claim 11 , wherein the hydrogel has a conductivity between about 0.1 S/m to about 1.0 S/m.

17. The device of claim 1 , wherein the module capable of performing sequencing is a module capable of performing Sanger sequencing.

18. The device of claim 17 , wherein the module capable of performing Sanger sequencing comprises a module capable of capillary electrophoresis, a module capable of multi-color fluorescence detection, or a combination thereof.

19. The device of claim 1 , wherein the module capable of performing sequencing is a module capable of performing next generation sequencing.

20. The device of claim 19 , wherein the module capable of performing next-generation sequencing is capable of performing pyrosequencing, ion semiconductor sequencing, polony sequencing, sequencing by ligation, DNA nanoball sequencing, or single molecule sequencing.

Assignments (3)
SECURITY INTEREST Recorded Jun 12, 2024
From: BIOLOGICAL DYNAMICS, INC.
To: THE JACOBS FAMILY TRUST DATED JUNE 2, 1980, SEPARATE PROPERTY OF IRWIN MARK JACOBS
Reel/Frame 067712/0940 →
SECURITY INTEREST Recorded Mar 2, 2023
From: BIOLOGICAL DYNAMICS, INC.
To: PARIAN ZEUS LP, IN ITS CAPACITY AS COLLATERAL AGENT ON BEHALF OF THE SECURED PARTIES
Reel/Frame 062917/0195 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2017
From: KRISHNAN, RAJARAM; CHARLOT, DAVID; TU, EUGENE; MCCANNA, JAMES; KUMOSA, LUCAS; SWANSON, PAUL; TURNER, ROBERT; YANG, KAI; DOBROVOLSKAYA, IRINA; LIU, DAVID
To: BIOLOGICAL DYNAMICS, INC.
Reel/Frame 042170/0687 →
Continuity (5)
Continuation 14925157 · Oct 28, 2015
Continuation 14067841 · Oct 30, 2013
Continuation 13864179 · Apr 16, 2013
Provisional Application 61624897 · Apr 16, 2012
Related Publication 20170072395A1 · Mar 16, 2017